InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Mahadevia Ankit, Chairman & CEO. Insider active across 1 companies, notably Spero Therapeutics, Inc.. In total, 6 disclosures have been published. The latest transaction was disclosed on 1 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
0134,168 shares0
Common Stock
SEC:0000899243-22-004591·
0134,168 shares0
Common Stock
SEC:0000899243-22-004591:0·
€41,6808,000 shares@ €5.21010.032% mcap100.0% of flow
Common Stock
SEC:0000899243-21-050049·
€41,6808,000 shares@ €5.21010.032% mcap50.0% of flow
Common Stock
SEC:0000899243-21-050049:0·
078,219 shares0
Common Stock
SEC:0000899243-21-034502·
078,219 shares0
Common Stock
SEC:0000899243-21-034502:0·
6 of 6 declarations
About Mahadevia Ankit
Mahadevia Ankit is the Chairman and CEO of Spero Therapeutics, Inc. He leads the company with a vision focused on innovation in developing treatments for rare diseases. His leadership is essential in guiding Spero's research and development efforts.
